An updated version of the eSubmission Gateway XML delivery file user interface is now available. The eSubmission Gateway update has introduced an additional submission unit for PAM submissions and a mandatory selection of yes/no to indicate if a change of MAH is included in a response submission for MAA human and vet. Additionally some minor [...]
A new version of the eSubmission Gateway XML delivery file user interface is now available. Following this release the use of the Formatted Letter template will become obsolete as of 1st January 2020. This will concern all EMA Human and Veterinary submissions (including PSUSA procedures) and after this it will be optional for applicants to [...]
PSUR and eSubmissions Web User Interface (to create the delivery file) will be unavailable between 07:00-09:00hrs (CEST) on Wednesday, 9 October 2019. However, the EMA gateway will remain available for all communities throughout and any files submitted during that time will be queued for processing when the work is complete. If you have any questions, [...]
VIMPAT 10 MG/ML JARABE, 1 frasco de 200 ml. Retirada del mercado de todas las unidades distribuidas del lote 5845802 y devolución al laboratorio por los cauces habituales.
La AEMPS ha recibido un número elevado de notificaciones de sospechas de falta de eficacia de Maxivac Hepta (nº reg. 1509 ESP), ya que el medicamento habría sido administrado como primovacunación, en lugar de como revacunación anual, tal y como se especifica en la ficha técnica del medicamento. Se informa a los profesionales sanitarios veterinarios [...]
Madrid, 14 de octubre de 2019
Version 1.23.1.3 of the 4 electronic Application Forms (eAF) will be available 10 October 2019. The release v1.23.1.3 is a bug fix release to correct a number of issues affecting the forms. More details on the fixes will be available in the release notes which will be published together with the updated forms. This hotfix [...]
Retirada del mercado de todas las unidades distribuidas de los lotes de este medicamento y devolución al laboratorio por los cauces habituales
Retirada del mercado de todas las unidades distribuidas de los lotes de este medicamento y devolución al laboratorio por los cauces habituales